The GLP-1 battle heats up with new preliminary data from Eli Lilly showing that patients using its weight loss drug Zepbound lost more...
ByglobalreutersDecember 4, 2024Bowel cancer vs colon cancer are two common types of cancer that affect the digestive system. These terms are often used interchangeably, but...
ByglobalreutersDecember 4, 2024Lyle Berkowitz is an old friend and these days is CEO of Keycare, which provides a virtual care workforce, primarily for major health...
ByglobalreutersDecember 4, 2024That is the title of an interview with me in The Evidence Base out today with the subtitle Introducing generalized cost effectiveness analysis...
ByglobalreutersDecember 4, 2024This updated fact sheet examines the U.S. role in the Global Fund, an independent, multilateral financing entity that raises significant new resources to...
ByglobalreutersDecember 3, 2024Keros Therapeutics will present Phase 2 data for the drug, elritercept, at the annual meeting of the American Society of Hematology. Meanwhile, the...
ByglobalreutersDecember 3, 2024A new issue brief based on focus groups conducted by KFF among NHPI adults living in Hawaii and the continental U.S. highlights barriers...
ByglobalreutersDecember 3, 2024সৌম্য হাড়ের টিউমার একটি উদ্বেগজনক রোগ নির্ণয় হতে পারে, তবে ভালো বিষয় হল এগুলি অ-ক্যান্সার এবং সাধারণত সঠিক চিকিৎসা যত্নের মাধ্যমে পরিচালনা করা...
ByglobalreutersDecember 3, 2024Sean Bell is head of new ventures at Spring Health, a very well-funded mental health company. They’ve built a tech platform that its...
ByglobalreutersDecember 3, 2024Meng Li (2024) has a nice summary of the generalized cost effectiveness analysis (GCEA) user guide paper (see Shafrin et al. 2024) that...
ByglobalreutersDecember 3, 2024